C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

BACKGROUND: At present, node-negative, high-risk breast cancer patients cannot be identified with sufficient accuracy. Consequently, further strong prognostic factors are needed. METHODS: Among 181 node-negative breast cancer (NNBC) patients, c-myc and HER-2/neu oncogenes were identified prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlotter, Claus M, Vogt, Ulf, Bosse, Ulrich, Mersch, Berthold, Waβmann, Katja
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2003
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154146/
https://www.ncbi.nlm.nih.gov/pubmed/12631396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC154146/
https://www.ncbi.nlm.nih.gov/pubmed/12631396

Ejemplares similares